- 2018 Annual Meeting Sponsors (21)
- 2019 Annual Meeting Sponsors (30)
- 2020 Annual Meeting Sponsors (17)
- ACL Blog: Stem Cells in Focus (28)
- Award Announcements (14)
- Events (29)
- Member News Items (163)
- Membership Application Requirements (4)
- Past Symposia (1)
- Past Symposia Programs (6)
- Policy News (97)
- Press Releases/Statements (132)
- Statements (81)
- Stem Cell Meetings (3)
- Stem Cell Reports Article (3)
- Year in Review (3)
-
-
-
-
-
-
-
ISSCR Urges UK Agency to Increase Enforcement for the Marketing of Unproven Products
The ISSCR writes UK agency to urge for increased enforcement activities to prevent the marketing and commercialization of stem cell-related products.Full story -
ISSCR Comments on Need to Improve ClinicalTrials.gov Database to Prevent Abuse
The ISSCR issues a comment letter urging that more efforts must be made to prevent the ClinicalTrials.gov database from being abused by clinics marketing unproven stem cell interventions.Full story -
ISSCR Statement on Ethical Standards for Stem Cell-based Embryo Models
The ISSCR is updating its Guidelines for Stem Cell Research and Clinical Translation to respond to recent scientific advances that include the use of pluripotent stem cell (PSC) to create models of early human embryo development.Full story -
The “I” in the ISSCR
The International Society for Stem Cell Research (ISSCR) is just that, an international organization. We work across the globe to promote excellence in stem cell science and applications to human health. The society advances international initiatives including: policy and advocacy, professional standards, building working relationships to stay abreast of emerging areas of interest, and of course educational meetings.Full story -
The ISSCR Hosts Ethics Workshop in China
The ISSCR and the Guangzhou Institute of Biomedicine and Health held a two-day workshop in Guangzhou, China. A small group of scientists and ethicists from around the world met to discuss ethical, scientific, and societal challenges in regenerative medicine.Full story -
The ISSCR is Updating its Guidelines
Stem cell science, its clinical application, and the ethical issues surrounding it have rapidly advanced since the release of the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation. The latest update will address important scientific, ethical, and regulatory issues, including embryo models, organoids, chimeras, genome editing, and the regulation and economics of cell therapies.Full story -
ISSCR Comments on Brazil’s Advanced Therapy Medicinal Products Regulation
The ISSCR submitted comments to Brazil’s health regulatory agency (ANVISA) regarding the proposed regulations for advanced therapy medicinal products that urge national governments to “maintain rigorous review pathways to ensure that stem cell-based products conform to the highest standards of evidence-based medicine.”Full story -
Lawrence Goldstein Policy Fellows Announced
The ISSCR is pleased to announce the recipients of the inaugural Lawrence Goldstein Policy Fellowship, Mohamed Abou El-Enein, PhD (Charité Universitätsmedizin, Berlin, Germany) and Zubin Master, PhD (Mayo Clinic, Rochester, MN, U.S.).Full story -
ISSCR Policy Advocacy in Action
Polices created by legislators and regulators can have a profound impact on stem cell and biomedical research and the development of new treatments. The ISSCR has been working on several fronts to advocate for responsible stem cell research and its application. Read more about the recent ISSCR-led fly in to Washington D.C. for discussions with government officials and our consultations with Google to prevent the marketing of unproven stem cell therapies.Full story -
ISSCR Applauds Google’s New Policy Banning Ads on Unproven Therapies
The International Society for Stem Cell Research (ISSCR) today released the following statement regarding Google’s new policy that bans advertisements from unproven stem cell clinics and other speculative medical interventions.Full story -
The ISSCR Releases Informed Consent Standard for Stem Cell-based Interventions
The International Society for Stem Cell Research (ISSCR) today released a professional standard of informed consent for stem cell-based interventions performed outside of formal clinical trials, such as the unapproved and unproven “treatments” offered by clinicians at direct-to-consumer clinics. The standard is meant to help ensure that patients are informed about the potential benefits and risks of stem cell-based medical interventions, and was developed with input from clinicians, ethicists, researchers, and regulators from around the world.Full story -
The ISSCR Announces Establishment of Lawrence Goldstein Science Policy Fellowship
The ISSCR honored longtime member Lawrence Goldstein for his years of science policy advocacy, and announced a new program in his name that will train ISSCR members to become stem cell policy advocates. The tribute and introduction of the Lawrence Goldstein Science Policy Fellowship program was part of the opening plenary session of the ISSCR annual meeting, 26-29 in Los Angeles, Calif., U.S.Full story -
ISSCR Supports Amendment in U.S. Congress to Prevent Fetal Tissue Research Funding Restrictions
The ISSCR and other medical, scientific, educational, and healthcare groups sent a letter to members of the U.S. Congress supporting an amendment that would prevent the implementation of a new policy to restrict and delay federal funding for fetal tissue research.Full story -
ISSCR Applauds Landmark Court Ruling in Favor of FDA Regulating Stem Cell Therapies Offered by Florida Clinic
The ISSCR commends the U.S. District Court ruling that confirms the FDA’s authority to regulate clinics marketing and selling unproven therapies as stem cell products. The clinic, U.S. Stem Cell, has injected cells derived from fat into the eyes of several patients, resulting in at least three being blinded.Full story